CANNABIS POLAND AB ZY-10 (8TE) - Total Liabilities
Based on the latest financial reports, CANNABIS POLAND AB ZY-10 (8TE) has total liabilities worth €1.49 Million EUR (≈ $1.74 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 8TE operating cash flow to assess how effectively this company generates cash.
CANNABIS POLAND AB ZY-10 - Total Liabilities Trend (2021–2025)
This chart illustrates how CANNABIS POLAND AB ZY-10's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of CANNABIS POLAND AB ZY-10 to evaluate the company's liquid asset resilience ratio.
CANNABIS POLAND AB ZY-10 Competitors by Total Liabilities
The table below lists competitors of CANNABIS POLAND AB ZY-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Portofino Resources Inc
V:POR
|
Canada | CA$1.50 Million |
|
Colibri Resource Corp
V:CBI
|
Canada | CA$1.98 Million |
|
Canada Carbon Inc.
V:CCB
|
Canada | CA$2.58 Million |
|
Northcliff Citranusa Indonesia Tbk PT
JK:SKYB
|
Indonesia | Rp7.94 Billion |
|
Warpaint London PLC
LSE:W7L
|
UK | GBX31.72 Million |
|
KATORO GOLD PLC LS-01
F:622
|
Germany | €437.10K |
|
Heads UP Ventures Limited
NSE:HEADSUP
|
India | Rs83.36 Million |
|
Fram Skandinavien AB Series B
ST:FRAM-B
|
Sweden | Skr17.02 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down CANNABIS POLAND AB ZY-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 8TE market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CANNABIS POLAND AB ZY-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CANNABIS POLAND AB ZY-10 (2021–2025)
The table below shows the annual total liabilities of CANNABIS POLAND AB ZY-10 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.49 Million ≈ $1.74 Million |
+129.01% |
| 2024-12-31 | €649.09K ≈ $758.85K |
+35.18% |
| 2023-12-31 | €480.16K ≈ $561.36K |
+39.56% |
| 2022-12-31 | €344.04K ≈ $402.22K |
+93.05% |
| 2021-12-31 | €178.22K ≈ $208.36K |
-- |
About CANNABIS POLAND AB ZY-10
Cannabis Poland S.A. operates in the medical cannabis industry in Poland. The company distributes and sells cannabidiol (CBD) oils and herbs, inhalers, and vaporizers, as well as dietary supplements and cosmetics for humans and animals. It sells its products through HempWish.pl and Vapem.eu online stores. The company also engages in the research and development of CBD-based drugs based on scienti… Read more